Aceprometazine

醋异丙嗪

Report date: 2022/02/17 16:24:57
NME

Base Information

Drug NameAceprometazine
Drug Alias Nameaceprometazina丙羟乙酰异丙嗪aceprometazinum16-64-CB
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor inverse agonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN05C